Money Concepts Capital Corp Soligenix, Inc. Transaction History

Money Concepts Capital Corp

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 18, 2022	SELL	$0.4 - $0.75 $2,520 - $4,725	-6,300 Reduced 26.2%	17,750 $10,000
Q1 2022 May 13, 2022	BUY	$0.61 - $0.75 $3,843 - $4,725	6,300 Added 35.49%	24,050 $18,000
Q4 2021 Feb 14, 2022	SELL	$0.66 - $1.1 $1,980 - $3,300	-3,000 Reduced 14.46%	17,750 $12,000
Q1 2021 May 17, 2021	BUY	$1.31 - $2.35 $1,310 - $2,350	1,000 Added 5.06%	20,750 $32,000
Q4 2020 May 17, 2021	BUY	$1.26 - $2.75 $24,885 - $54,312	19,750 New	19,750 $25,000

Ticker SNGX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 43,105,200
Market Cap $125M
Description
Soligenix, Inc., a late-stage biopharmaceutical company, focuses on developing and commercializing products to treat rare diseases in the United States. It operates in two segments, Specialized BioTherapeutics and Public Health Solutions. The Specialized BioTherapeutics segment develops SGX301 (HyBryte), a novel photodynamic therapy, which has c...

Get notified when there are updates to the investment portfolio of Money Concepts Capital Corp, based on Form 13F filings with the SEC.

Stay updated on Money Concepts Capital Corp with notifications on news.